metastatic colorectal cancer

You have access
Comparative Effectiveness of Cetuximab Versus Panitumumab in Patients With Metastatic Colorectal Cancer: A Nationwide Database Study
CHIH-CHIEN WU, CHIEN-CHOU SU, YU-HSUN CHEN, CHAO-WEN HSU, MENG-CHE HSIEH, YU-CHING CHANG, YUNG-CHANG WANG and YI-CHIA SU

Anticancer Research November 2023, 43 (11) 5127-5138; DOI: https://doi.org/10.21873/anticanres.16713
You have access
Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer
MING XU, RYOUICHI TSUNEDOMI, KAZUMA KIYOTANI, SHINOBU TOMOCHIKA, KEI FURUYA, MASAO NAKAJIMA, HIROTO MATSUI, YUKIO TOKUMITSU, YOSHITARO SHINDO, SHIN YOSHIDA, MICHIHISA IIDA, NOBUAKI SUZUKI, SHIGERU TAKEDA, TATSUYA IOKA, SHOICHI HAZAMA and HIROAKI NAGANO

Anticancer Research February 2023, 43 (2) 613-620; DOI: https://doi.org/10.21873/anticanres.16197
Open Access
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
HIKARI CHIDIMATSU, RYOUICHI TSUNEDOMI, YUKI NAKAGAMI, MING XU, MASAO NAKAJIMA, CHIYO NAKASHIMA-NAKASUGA, SHINOBU TOMOCHIKA, SHIN YOSHIDA, NOBUAKI SUZUKI, YUSAKU WATANABE, HIROTO MATSUI, YOSHITARO SHINDO, YUKIO TOKUMITSU, MICHIHISA IIDA, SHIGERU TAKEDA, TATSUYA IOKA, TOMIO UENO, TSUYOSHI TANABE, YOSHINOBU HOSHII, SHOICHI HAZAMA and HIROAKI NAGANO

Anticancer Research January 2023, 43 (1) 105-114; DOI: https://doi.org/10.21873/anticanres.16139
You have access
A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
AYA KATO, NORIKATSU MIYOSHI, TORU OHTSURU, DAISUKE SAKAI, JUNICHI HASEGAWA, KEN NAKATA, MITSUNOBU IMASATO, TAKESHI KATO, MASAKAZU IKENAGA, TOSHIHIRO KUDO, MITSUYOSHI TEI, YOSHINORI KAGAWA, MAMORU UEMURA, HIDEKAZU TAKAHASHI, TAROH SATOH, MASAKI MORI, TSUNEKAZU MIZUSHIMA, HIROFUMI YAMAMOTO, KOHEI MURATA, YUICHIRO DOKI and HIDETOSHI EGUCHI

Anticancer Research April 2022, 42 (4) 1859-1865; DOI: https://doi.org/10.21873/anticanres.15662
You have access
The Efficacy and Safety of Trifluridine/Tipiracil Treatment for Elderly Patients With Metastatic Colorectal Cancer in a Real-world Setting
MASATSUNE SHIBUTANI, WANG EN, YUKI OKAZAKI, SHINICHIRO KASHIWAGI, TATSUNARI FUKUOKA, YASUHITO ISEKI, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research December 2021, 41 (12) 6211-6216; DOI: https://doi.org/10.21873/anticanres.15440
You have access
Clinical Impact of Primary Tumor Location and RAS, BRAF V600E, and PIK3CA Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer
TARO SATO, HIROKI OSUMI, EIJI SHINOZAKI, AKIRA OOKI, KEITARO SHIMOZAKI, DAISAKU KAMIIMABEPPU, IZUMA NAKAYAMA, TAKERU WAKATSUKI, MARIKO OGURA, DAISUKE TAKAHARI, KEISHO CHIN and KENSEI YAMAGUCHI

Anticancer Research August 2021, 41 (8) 3905-3915; DOI: https://doi.org/10.21873/anticanres.15186
You have access
Risk–benefit Analysis of FOLFIRI Plus Ramucirumab/Aflibercept as a Third-line Treatment in Metastatic Colorectal Cancer
MICHIO KIMURA, EISEKI USAMI, HITOMI TERAMACHI and TOMOAKI YOSHIMURA

Anticancer Research June 2021, 41 (6) 3091-3097; DOI: https://doi.org/10.21873/anticanres.15093
You have access
Prospective Multicenter Phase II Study of Biweekly TAS-102 and Bevacizumab for Metastatic Colorectal Cancer
TETSUO ISHIZAKI, JUNICHI MAZAKI, MASANOBU ENOMOTO, MASATOSHI SHIGOKA, KENTA KASAHARA, TAKAAKI MATSUDO, HIDEAKI KAWAKITA, YUICHI NAGAKAWA, KENJI KATSUMATA and AKIHIKO TSUCHIDA

Anticancer Research April 2021, 41 (4) 2157-2163; DOI: https://doi.org/10.21873/anticanres.14988
You have access
Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment
YUSUKE NIISATO, TOSHIKAZU MORIWAKI, SHOTA FUKUOKA, TOSHIKI MASUISHI, ATSUO TAKASHIMA, YOSUKE KUMEKAWA, TAKESHI KAJIWARA, KENTARO YAMAZAKI, TAITO ESAKI, AKITAKA MAKIYAMA, TADAMICHI DENDA, YUKIMASA HATACHI, TAKESHI SUTO, NAOTOSHI SUGIMOTO and YASUHIRO SHIMADA

Anticancer Research April 2021, 41 (4) 2203-2207; DOI: https://doi.org/10.21873/anticanres.14996
You have access
Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU

Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809

Main menu

User menu

Search

metastatic colorectal cancer

Pages